Variant report

Variant	esv3437401
Chromosome Location	chr1:213082329-213088502
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr1:213087453..213089849-chr1:213098017..213100027,2	K562	blood:
2	chr1:212838488..212839107-chr1:213088444..213089233,2	K562	blood:
3	chr1:212988120..212988960-chr1:213088354..213089047,3	K562	blood:
4	chr1:213081058..213082812-chr1:213090244..213092808,2	K562	blood:
5	chr1:212987850..212988584-chr1:213088350..213088901,2	MCF-7	breast:
6	chr1:213088299..213089124-chr10:91087481..91088095,2	Hela-S3	cervix:
7	chr1:212963885..212966841-chr1:213087848..213090181,3	K562	blood:

Variant related genes	Relation type
ENSG00000119917	chromatin interactions
ENSG00000237980	chromatin interactions
ENSG00000203705	chromatin interactions
ENSG00000117697	chromatin interactions

Extended variants
information (count: 332 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:332 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs572056941	chr1:213082341-213082342	Genic enhancers Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs372765446	chr1:213082415-213082416	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
3	rs561807867	chr1:213082423-213082424	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
4	rs75570815	chr1:213082428-213082429	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
5	rs577545002	chr1:213082429-213082430	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
6	rs114162177	chr1:213082471-213082472	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
7	rs190794936	chr1:213082532-213082533	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
8	rs200617910	chr1:213082547-213082548	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
9	rs34901157	chr1:213082550-213082551	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
10	rs143618750	chr1:213082555-213082556	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
11	rs34250309	chr1:213082556-213082557	Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
12	rs34842833	chr1:213082637-213082638	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
13	rs71147047	chr1:213082656-213082657	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
14	rs182842226	chr1:213082666-213082667	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
15	rs2644550	chr1:213082679-213082680	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs187168188	chr1:213082700-213082701	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
17	rs551918694	chr1:213082705-213082706	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
18	rs6671740	chr1:213082721-213082722	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs531430778	chr1:213082731-213082732	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
20	rs549663150	chr1:213082734-213082735	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
21	rs529155929	chr1:213082759-213082760	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
22	rs528880074	chr1:213082787-213082788	Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
23	rs35345493	chr1:213082813-213082814	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
24	rs397949984	chr1:213082827-213082828	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
25	rs147859569	chr1:213082836-213082837	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
26	rs67340916	chr1:213082865-213082866	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
27	rs71665981	chr1:213082868-213082869	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
28	rs553494021	chr1:213082876-213082877	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
29	rs565743652	chr1:213082882-213082883	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
30	rs539522810	chr1:213082907-213082908	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
31	rs6660933	chr1:213082908-213082909	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs6663568	chr1:213082921-213082922	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs544858695	chr1:213082934-213082935	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
34	rs556774854	chr1:213082953-213082954	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
35	rs575033076	chr1:213082966-213082967	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
36	rs2487265	chr1:213083016-213083017	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs6697099	chr1:213083036-213083037	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs374276941	chr1:213083076-213083077	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs143563403	chr1:213083125-213083126	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs368443464	chr1:213083130-213083131	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
41	rs6663574	chr1:213083136-213083137	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs114135810	chr1:213083177-213083178	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
43	rs568299149	chr1:213083188-213083189	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
44	rs529199077	chr1:213083194-213083195	Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
45	rs547337292	chr1:213083213-213083214	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs544872256	chr1:213083253-213083254	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs565515506	chr1:213083254-213083255	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs539483681	chr1:213083257-213083258	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs12760321	chr1:213083261-213083262	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs569774352	chr1:213083300-213083301	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Trisomy 5 syndrome	21098271	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
Multiple myeloma	16461302	CNVD
van der Woude syndrome	22470819	CNVD
van der Woude syndrome	20818247	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	17060936	CNVD
Atypical hemolytic uremic syndrome	19861685	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21720365	CNVD
small cell lung cancer	20016488	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Medulloblastoma	16783165	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Holoprosencephaly	19184110	CNVD
Breast cancer	21069454	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Mental retardation	19951919	CNVD
Non-syndromic sensorineural hearing loss	17873649	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD

Chromatin state (count:128 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:213073800-213089000	Weak transcription	Pancreas	Pancrea
2	chr1:213076800-213083600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr1:213079000-213082600	Genic enhancers	iPS-18 Cell Line	embryonic stem cell
4	chr1:213079600-213090000	Weak transcription	Right Atrium	heart
5	chr1:213079800-213082400	Genic enhancers	HUES6 Cell Line	embryonic stem cell
6	chr1:213079800-213082400	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr1:213080600-213083200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr1:213081400-213082400	Enhancers	HUES64 Cell Line	embryonic stem cell
9	chr1:213081400-213082800	Weak transcription	H9 Cell Line	embryonic stem cell
10	chr1:213081600-213082400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
11	chr1:213081600-213082600	Genic enhancers	ES-I3 Cell Line	embryonic stem cell
12	chr1:213081600-213082800	Weak transcription	HUES48 Cell Line	embryonic stem cell
13	chr1:213081600-213088000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr1:213081800-213083000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
15	chr1:213082000-213082400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
16	chr1:213082200-213082400	Enhancers	H1 Cell Line	embryonic stem cell
17	chr1:213082400-213082600	Flanking Active TSS	H1 Cell Line	embryonic stem cell
18	chr1:213082400-213082600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
19	chr1:213082400-213082600	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
20	chr1:213082400-213082600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
21	chr1:213082400-213082600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr1:213082400-213083200	Active TSS	ES-WA7 Cell Line	embryonic stem cell
23	chr1:213082400-213083200	Transcr. at gene 5' and 3'	iPS-20b Cell Line	embryonic stem cell
24	chr1:213082600-213082800	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr1:213082600-213082800	Enhancers	HUES64 Cell Line	embryonic stem cell
26	chr1:213082600-213083000	Enhancers	ES-I3 Cell Line	embryonic stem cell
27	chr1:213082600-213083000	Enhancers	H1 Cell Line	embryonic stem cell
28	chr1:213082600-213083000	Enhancers	iPS-15b Cell Line	embryonic stem cell
29	chr1:213082600-213083000	Enhancers	iPS-18 Cell Line	embryonic stem cell
30	chr1:213082600-213083600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
31	chr1:213082800-213083000	Active TSS	H9 Cell Line	embryonic stem cell
32	chr1:213082800-213083000	Enhancers	HUES48 Cell Line	embryonic stem cell
33	chr1:213082800-213083000	Active TSS	HUES64 Cell Line	embryonic stem cell
34	chr1:213082800-213083200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
35	chr1:213083000-213083200	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
36	chr1:213083000-213083200	Flanking Active TSS	H1 Cell Line	embryonic stem cell
37	chr1:213083000-213083200	Transcr. at gene 5' and 3'	H9 Cell Line	embryonic stem cell
38	chr1:213083000-213083200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
39	chr1:213083000-213083200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
40	chr1:213083000-213083200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
41	chr1:213083000-213083200	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
42	chr1:213083000-213083400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr1:213083000-213083400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
44	chr1:213083200-213083400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
45	chr1:213083200-213084200	Active TSS	H1 Cell Line	embryonic stem cell
46	chr1:213083200-213084200	Active TSS	HUES48 Cell Line	embryonic stem cell
47	chr1:213083200-213084200	Active TSS	HUES6 Cell Line	embryonic stem cell
48	chr1:213083200-213084200	Active TSS	iPS-15b Cell Line	embryonic stem cell
49	chr1:213083200-213084200	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
50	chr1:213083200-213084600	Active TSS	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links